health pharma news today obesity drugs glp-1 today Chart: 1 in 8 Americans Now Use for Weight Loss World Health Organization recommends GLP-1

, A role for glucagon-like peptide-1 in the central regulation of feeding

Even after the shortages for both drugs ended as per the FDA, the American Society of Health-System Pharmacists (ASHP), for example, only declared them resolved in a 5 March update

10.1136/bmj.q1645 [DOI] [PubMed] [Google Scholar] 10.Gulak MA, Murphy P

Orforglipron's lower manufacturing costs, room-temperature stability, and oral formulation could make effective obesity pharmacotherapy accessible to populations in low- and middle-income countries for the first time, representing a significant advance in global health equity

10.3390/jcm13164934 [DOI] [PMC free article] [PubMed] [Google Scholar] 23

Data were obtained from Truveta Data, which provides EHR data across 30 US healthcare systems